Evolution: To plasticity and back again
It was the Danish botanist Wilhelm Johannsen who coined the terms ‘genotype’ and ‘phenotype’. He thought that the genotype, or genetic makeup, of an organism referred to its ‘fundamental constitution’, whereas an organism's individual characters or traits, i.e. its phenotype, arose from a complicated interaction between the genotype and the environment (Johannsen, 1913).
Phenotypes can vary in response to external factors such as nutrition and temperature (Woltereck, 1909); this can be simply an accidental consequence of the fact that cellular and developmental processes that produce the phenotype run at different rates under different environmental conditions. And because environments are seldom, if ever, stable, it is very common for there to be some natural variation in phenotypes around some ‘ideal’ value, even between individuals with identical genotypes.
A natural question to ask is—does this variation matter? In terms of evolution, what matters are things that affect fitness: that is, things that affect the ability of an individual, compared to other individuals, to pass its genes to the next generation. If the phenotypic variation reduces fitness, then selection will favor the evolution of mechanisms that make the phenotype more robust, or less sensitive to environmental variation. On the other hand, if some of the phenotypes are well adapted to the environmental factors that induce them, evolution will favor mechanisms that stabilize the production of each phenotype in its best-suited environment.
When one genotype can produce more than one phenotype in different environments, this is generally referred to as ‘phenotypic plasticity’. As this ability can increase the diversity of phenotypes in a population, it is natural to ask whether populations of organisms with phenotypic plasticity are more able to evolve than those without. To date, there are various theories that suggest they should be, but there is little experimental evidence to support this view (Moczek et al., 2011; West-Eberhard, 2003). Now, in eLife, Ralf Sommer and Erik Ragsdale from the Max Planck Institute for Developmental Biology and co-workers—including Vladislav Susoy as first author—report that phenotypic plasticity is associated with evolutionary diversification in nematode worms (Susoy et al., 2015).
Susoy et al. examined a large group of nematode worms, including the model species Caenorhabditis elegans and some species with adults that have so-called ‘polyphenic’ mouthparts. Polyphenism is an extreme, but common, form of phenotypic plasticity in which two (or more) completely different phenotypes develop in response to specific environmental cues. Each of the alternative phenotypes is an adaptation to a different environment (Nijhout, 2003), and natural selection acts to ensure that they are stably and reliably produced to best match the environmental conditions.
Susoy et al. tested 90 species of nematodes for their ability to develop polyphenic mouthparts in the laboratory. In 23 species, some worms developed small smooth mouths specialized for feeding on bacteria, whereas others of the same species developed mouths with hooks and teeth. The toothed phenotype is used to feed on fungi and on other nematodes, and is induced by overcrowding and by starvation during the first larval stage (Bento et al., 2010; Sommer and Ogawa, 2011).
Analysis of the evolutionary relationships between the nematodes revealed that polyphenic mouthparts evolved only once in a common ancestor of the 23 species. Susoy et al. then asked if there was greater diversification in the shapes of mouthparts after polyphenism had evolved compared to the lineages of the ‘nematode family tree’ that had not evolved polyphenism. A sophisticated statistical analysis showed that this was indeed the case. This is some of the best empirical evidence to date for the theory that phenotypic plasticity enhances the ability of a population to evolve new forms (also known as evolvability).
Moreover, although polyphenism evolved only once, it appears to have been lost at least 10 times during the subsequent evolution of the lineage. Unexpectedly, the loss of polyphenism was followed by an even stronger rate of subsequent evolution of new traits and phenotypes. Thus the loss of phenotypic plasticity was also associated with an increase in evolvability. But how can this be explained?
One possible explanation is that a polyphenism requires developmental mechanisms that stabilize two alternative phenotypes, each in a different environment. If they work well, such stabilizing mechanisms buffer the two phenotypes against moderate changes to the organism's genetic makeup. This means that many mutations will not effect the phenotype and therefore will not be selected against. Such mutations will gradually accumulate in a population (Figure 1). Then, when the polyphenism is lost, the need to stabilize one of the two phenotypes disappears. Thus some of the accumulated genetic variation is no longer buffered and can cause the phenotype to vary more. This new phenotypic variation can now come under selection and lead to diverse adaptations in different lineages.
It is important to note that this explanation is, of course, a thought experiment that could be supported by statistical analyses. But the great challenge for the future will be to establish whether it is possible to devise experiments that can prove whether such a mechanism exists in nature.
References
-
The role of developmental plasticity in evolutionary innovationProceedings of the Royal Society B: Biological Sciences 278:2705–2713.https://doi.org/10.1098/rspb.2011.0971
-
Development and evolution of adaptive polyphenismsEvolution & Development 5:9–18.https://doi.org/10.1046/j.1525-142X.2003.03003.x
-
Weitere experimentelle Untersuchungen über Artveränderung, speziell über das Wesen quantitativer Artunterschiede bei DaphnienVerhandlungen der Deutschen Zoologischen Gesellschaft 19:110–173.
Article and author information
Author details
Publication history
Copyright
© 2015, Nijhout
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,661
- views
-
- 252
- downloads
-
- 8
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Evolutionary Biology
With the availability of high-quality full genome polymorphism (SNPs) data, it becomes feasible to study the past demographic and selective history of populations in exquisite detail. However, such inferences still suffer from a lack of statistical resolution for recent, for example bottlenecks, events, and/or for populations with small nucleotide diversity. Additional heritable (epi)genetic markers, such as indels, transposable elements, microsatellites, or cytosine methylation, may provide further, yet untapped, information on the recent past population history. We extend the Sequential Markovian Coalescent (SMC) framework to jointly use SNPs and other hyper-mutable markers. We are able to (1) improve the accuracy of demographic inference in recent times, (2) uncover past demographic events hidden to SNP-based inference methods, and (3) infer the hyper-mutable marker mutation rates under a finite site model. As a proof of principle, we focus on demographic inference in Arabidopsis thaliana using DNA methylation diversity data from 10 European natural accessions. We demonstrate that segregating single methylated polymorphisms (SMPs) satisfy the modeling assumptions of the SMC framework, while differentially methylated regions (DMRs) are not suitable as their length exceeds that of the genomic distance between two recombination events. Combining SNPs and SMPs while accounting for site- and region-level epimutation processes, we provide new estimates of the glacial age bottleneck and post-glacial population expansion of the European A. thaliana population. Our SMC framework readily accounts for a wide range of heritable genomic markers, thus paving the way for next-generation inference of evolutionary history by combining information from several genetic and epigenetic markers.
-
- Computational and Systems Biology
- Evolutionary Biology
There is growing interest in designing multidrug therapies that leverage tradeoffs to combat resistance. Tradeoffs are common in evolution and occur when, for example, resistance to one drug results in sensitivity to another. Major questions remain about the extent to which tradeoffs are reliable, specifically, whether the mutants that provide resistance to a given drug all suffer similar tradeoffs. This question is difficult because the drug-resistant mutants observed in the clinic, and even those evolved in controlled laboratory settings, are often biased towards those that provide large fitness benefits. Thus, the mutations (and mechanisms) that provide drug resistance may be more diverse than current data suggests. Here, we perform evolution experiments utilizing lineage-tracking to capture a fuller spectrum of mutations that give yeast cells a fitness advantage in fluconazole, a common antifungal drug. We then quantify fitness tradeoffs for each of 774 evolved mutants across 12 environments, finding these mutants group into classes with characteristically different tradeoffs. Their unique tradeoffs may imply that each group of mutants affects fitness through different underlying mechanisms. Some of the groupings we find are surprising. For example, we find some mutants that resist single drugs do not resist their combination, while others do. And some mutants to the same gene have different tradeoffs than others. These findings, on one hand, demonstrate the difficulty in relying on consistent or intuitive tradeoffs when designing multidrug treatments. On the other hand, by demonstrating that hundreds of adaptive mutations can be reduced to a few groups with characteristic tradeoffs, our findings may yet empower multidrug strategies that leverage tradeoffs to combat resistance. More generally speaking, by grouping mutants that likely affect fitness through similar underlying mechanisms, our work guides efforts to map the phenotypic effects of mutation.